CD4 and type 1 diabetes mellitus: The protocol for Treg therapy in T1D patients required the transfer of ex vivo-expanded autologous polyclonal CD4+CD127lo/-CD25+ Treg cells within 6 weeks of diagnosis (55, 58, 62).